How to Buy Decoy Therapeutics Stock
Decoy Therapeutics Inc
Decoy Therapeutics, Inc. is a preclinical-stage biotechnology company that is leveraging machine learning and AI tools alongside high-speed synthesis techniques to rapidly design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs.
Decoy Therapeutics stock last closed at $0.68, up 0.15% from the previous day, and has decreased 96.86% in one year. It has underperformed other stocks in the Biotechnology industry by 0.78 percentage points. Decoy Therapeutics stock is currently +32.62% from its 52-week low of $0.52, and -98.03% from its 52-week high of $34.65.
As of Feb 26, 2026, there are 5.86M shares of DCOY outstanding. The market value of DCOY is $4.00M. In the past 24 hours, 68,000 DCOY shares were traded.
How to Buy Decoy Therapeutics Stock
Not sure how to invest in Decoy Therapeutics stock? Here's how.
- Decide where to buy Decoy Therapeutics stock: You need to pick an online brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you decide where to buy Decoy Therapeutics stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit funds into your investment account: Choose your payment method and add your details.
- Evaluate Decoy Therapeutics stock: The Decoy Therapeutics ticker symbol is DCOY. Is Decoy Therapeutics stock a good investment? Should you buy shares of DCOY? How do DCOY's underlying business fundamentals look? Do top analysts think Decoy Therapeutics is a good buy? Why has DCOY's stock price moved recently? (Hint: Our stock market analysis website can help you understand if DCOY is a good stock to buy).
- Execute your DCOY purchase: Decide if you will purchase DCOY shares at the current market price or use a limit order to buy DCOY shares at a specific price.
- Get notifications regarding your investment in DCOY: Create a watchlist to important updates regarding your new investment in Decoy Therapeutics stock.
Step 1: Decide where to buy Decoy Therapeutics stock
You will need a brokerage account in order to access the NASDAQ market and buy DCOY stock.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world financial markets: From Tech to Real Estate, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked the right brokerage, it's time to fill out some personal information so you are able to invest in DCOY stock today.
How to Set Up a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to start a new brokerage account.
- Submit your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you've created your account on our top ranked stock market app, you need to deposit funds:
Check out the walkthrough below for more details transferring funds into your new investment account.
Step 4: Evaluate Decoy Therapeutics stock
After you have figured out the best place to buy Decoy Therapeutics stock, it's crucial to evaluate their stock prior to buying, so you truly wrap your head around the risk as well as the upside.
Decoy Therapeutics Metrics
DCOY Overview
WallStreetZen was built to help part-time investors do more accurate fundamental analysis quickly.
You can view all of the due diligence checks on DCOY's stock page.
What is the fair value of DCOY stock?
You can use many financial metrics, analyses, models, and charts to gauge DCOY's intrinsic value.
Using relative valuations methods:
- DCOY may be undervalued based on its P/B ratio of 0.94x, relative to Biotechnology industry P/B ratio of 4.94x
You can do more valuation analysis on DCOY's stock here.
DCOY Financial Health
Passed Financial Due Diligence Checks:
- DCOY has $4.81M in cash and short term investments. This is enough to cover its annual cash burn of $4.43M.
- DCOY has cash burn of 4433218. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the DCOY balance sheet.
- There are more short-term assets than long-term liabilities on the DCOY balance sheet.
Failed Financial Due Diligence Checks:
- Total DCOY debt is higher than 5 years ago, relative to shareholder equity.
- DCOY has a relatively high debt to equity ratio of 0.44.
Do analysts think it's a good time to buy DCOY stock
Out of 1 Equities analysts who give recommendations on DCOY, the consensus analyst rating on DCOY is a Strong Buy
It's important to note that analyst ratings are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are saying on the Decoy Therapeutics stock forecast page.
Metrics for Advanced DCOY Traders
DCOY Growth Metrics
Last year, DCOY revenue was $0.00. Over the last five year, DCOY's revenue has grown by -100% per year. This was slower than the Biotechnology industry average of 33.87%.
Learn more about DCOY's earnings and revenue performance here.
Who is buying/selling DCOY?
Over the last 12 months, insiders at DCOY have bought more shares than they have sold.
Arnold C. Hanish, Director of DCOY, was the latest DCOY insider to sell. They sold $9.60 worth of DCOY shares on Dec 30, 2025.
Learn more about who owns DCOY stock here.
Does DCOY provide a stable income stream?
No, Decoy Therapeutics doesn't provide an income stream by paying out dividends.
What others are saying about DCOY
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Execute your DCOY purchase
You have two main options:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are usually fine. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a specific dollar amount, use a limit order.
Click the Open Trade button and eToro will execute your order.
If you require more info about investing in stocks on eToro, click the how to video below:
Step 6: Get notifications regarding your investment in DCOY
Now that you own some DCOY stock, you'll want to stay up-to-date on your new investment.
Put DCOY on a watchlist to get notified of the latest news about your DCOY stock.
DCOY Feed
How to Buy Stock in Decoy Therapeutics
To summarize, here are the 6 steps for buying Decoy Therapeutics stock:
- Decide where to buy Decoy Therapeutics stock
- Create your brokerage account
- Deposit funds into your investment account
- Evaluate Decoy Therapeutics stock
- Execute your DCOY purchase
- Get notifications regarding your investment in DCOY
If you are looking for a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get updates on your new investment in Decoy Therapeutics, click below.
Trending Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.